NGX-4010, a Capsaicin 8% Dermal Patch, Administered Alone or in Combination With Systemic Neuropathic Pain Medications, Reduces Pain in Patients With Postherpetic Neuralgia
Gordon Irving(Swedish Medical Center), Geertrui F. Vanhove, Lynn R. Webster(Adherent Technologies (United States)), Miroslav Bačkonja(University of Wisconsin–Madison), Jeffrey Tobias(Jazz Pharmaceuticals (United States)), Richard Rauck(Carolinas Pain Institute)
Cited by 68
Related Papers
Advances in Neuropathic Pain
|Archives of Neurology|2003|1.2k
Predicting Aberrant Behaviors in Opioid-Treated Patients: Preliminary Validation of the Opioid Risk Tool
|Pain Medicine|2005|1.1k
Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe Sepsis
|JAMA|2003|958
Recommendations for the Management of Herpes Zoster
|Clinical Infectious Diseases|2006|842
Risk Factors for Opioid-Use Disorder and Overdose
|Anesthesia & Analgesia|2017|504